Tobacco giant buys rights to lung cancer drugs
One of the world's biggest tobacco companies aims to make billions of dollars from diseases caused by cigarettes through deals with biotech companies for exclusive rights to future lung cancer
One of the world's biggest tobacco companies aims to make billions of dollars from diseases caused by cigarettes through deals with biotech companies for exclusive rights to future lung cancer